These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29960094)

  • 1. Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma.
    Zheng J; Wang C; Liu F
    World Neurosurg; 2018 Sep; 117():316-320. PubMed ID: 29960094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
    Pitini V; Baldari S; Altavilla G; Arrigo C; Naro C; Perniciaro F
    J Neurooncol; 2007 Jul; 83(3):291-3. PubMed ID: 17245621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
    Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
    Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide for relapsed primary CNS lymphoma.
    Osmani AH; Masood N
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
    Wong SF; Gan HK; Cher L
    J Clin Neurosci; 2012 Nov; 19(11):1501-5. PubMed ID: 22995759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of stereotactic radiation therapy combined with temozolomide on recurrent brain glioma].
    Zhao H; Liu S; Jiang C; Li X; Tang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):394-397. PubMed ID: 29774875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
    Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
    Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report.
    Makino K; Nakamura H; Kudo M; Takeshima H; Kuratsu J
    Neurol Med Chir (Tokyo); 2007 May; 47(5):229-32. PubMed ID: 17527051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report.
    Qie S; Yuan L; Shi HY; Zhang X; Li Y
    Medicine (Baltimore); 2019 Jan; 98(1):e13869. PubMed ID: 30608405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
    Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
    World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma as a neurosurgical problem.
    Szczepanek D; Wąsik-Szczepanek E; Stoma F; Sokołowska B; Trojanowski T
    Neurol Neurochir Pol; 2017; 51(4):319-323. PubMed ID: 28476199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
    Wong ET; Tishler R; Barron L; Wu JK
    Cancer; 2004 Jul; 101(1):139-45. PubMed ID: 15221999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Recognition and Initiation of Temozolomide Chemotherapy for Refractory, Invasive Pituitary Macroprolactinoma with Long-Term Sustained Remission.
    Barkhoudarian G; Palejwala SK; Ogunbameru R; Wei H; Eisenberg A; Kelly DF
    World Neurosurg; 2018 Oct; 118():118-124. PubMed ID: 30031177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
    Soussain C; Suzan F; Hoang-Xuan K; Cassoux N; Levy V; Azar N; Belanger C; Achour E; Ribrag V; Gerber S; Delattre JY; Leblond V
    J Clin Oncol; 2001 Feb; 19(3):742-9. PubMed ID: 11157026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of primary CNS lymphoma after more than 10 years in complete remission.
    Herrlinger U; Hebart H; Kanz L; Dichgans J; Weller M
    J Neurol; 2005 Nov; 252(11):1409-10. PubMed ID: 15895304
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
    Langner-Lemercier S; Houillier C; Soussain C; Ghesquières H; Chinot O; Taillandier L; Soubeyran P; Lamy T; Morschhauser F; Benouaich-Amiel A; Ahle G; Moles-Moreau MP; Moluçon-Chabrot C; Bourquard P; Damaj G; Jardin F; Larrieu D; Gyan E; Gressin R; Jaccard A; Choquet S; Brion A; Casasnovas O; Colin P; Reman O; Tempescul A; Marolleau JP; Fabbro M; Naudet F; Hoang-Xuan K; Houot R
    Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
    Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
    J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma.
    Murakami M; Fujimaki T; Asano S; Nakaguchi H; Yamada SM; Hoya K; Yamazaki K; Ishida Y; Matsuno A
    Yonsei Med J; 2011 Nov; 52(6):1031-4. PubMed ID: 22028172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.